Proactive Investors - Run By Investors For Investors

MGC Pharmaceuticals to reveal medical cannabis agreement

The halt will remain in place until Wednesday 3rd May 2017.
MGC Pharmaceuticals to reveal medical cannabis agreement
MGC has some major news pending

MGC Pharmaceuticals (ASX:MXC) is some interesting news pending with the execution of a material strategic agreement with the Royal Melbourne Institute of Technology (RMIT).

The agreement relates to the company’s Australian based medical cannabis operations, licensing and strategy.

The ASX has granted a trading halt for MGC to prepare.

The halt will remain in place until the opening of trade on Wednesday 3rd May 2017, or earlier if an announcement is made to the market.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full MXC profile View Profile

MGC Pharmaceuticals Ltd Timeline

Related Articles

cannabis leaf and green tablets
October 30 2018
The company will now proceed with stage II of the human clinical trial.
November 01 2018
The 35,000 sq ft automated facility is equipped with proprietary fertigation, operational and security systems
The Green Organic Dutchman windmill in a field
TGOD has been building out its facilities in Ontario, Quebec, and Jamaica, expecting to reach combined production of 170,000 kilograms of cannabis around 2020

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use